Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: The Diminishing Role of Adjuvant HIPEC

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Glehen O, Passot G, Villeneuve L, et al. GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer. 2014;14:183.

    Article  Google Scholar 

  2. Klaver CE, Wisselink DD, Punt CJ, et al. Adjuvant HIPEC in patients with colon cancer at high risk of peritoneal metastases: primary outcome of the COLOPEC multicenter randomized trial. J Clin Oncol. 2019;37(4 Suppl):482.

    Article  Google Scholar 

  3. Goere D, Glehen O, Quenet F, et al. Results of a randomized phase 3 study evaluating the potential benefit of a second-look surgery plus HIPEC in patients at high risk of developing colorectal peritoneal metastases. J Clin Oncol. 2018;36(15 Suppl):3531.

    Article  Google Scholar 

  4. Enomoto LM, Choudry MH, Bartlett DL, et al. Outcomes after adjuvant hyperthermic intraperitoneal chemotherapy for high-risk primary appendiceal neoplasms after complete resection. Ann Surg Oncol. Epub 31 Jul 2019. https://doi.org/10.1245/s10434-019-07634-y.

  5. Quenet F, Elias D, Roca L, et al. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. J Clin Oncol. 2018;36(18 Suppl):3503.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA

    Laura M. Enomoto MSc, MD & Perry Shen MD, FACS

Authors
  1. Laura M. Enomoto MSc, MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Perry Shen MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Perry Shen MD, FACS.

Ethics declarations

Disclosure

Laura M. Enomoto and Perry Shen report no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

ASO Author Reflections is a brief invited commentary on the article, “Outcomes After Adjuvant Hyperthermic Intraperitoneal Chemotherapy for High-Risk Primary Appendiceal Neoplasms After Complete Resection”, Ann Surg Oncol. Epub 31 Jul 2019. https://doi.org/10.1245/s10434-019-07634-y.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Enomoto, L.M., Shen, P. ASO Author Reflections: The Diminishing Role of Adjuvant HIPEC. Ann Surg Oncol 27, 115–116 (2020). https://doi.org/10.1245/s10434-019-08070-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-019-08070-8

Search

Navigation